/PRNewswire/ CureLab Veterinary, an emerging animal health biotech company, has launched its crowdfunding campaign via Netcapital, a leading investment.
BOSTON, USA and CAMERINO, ITALY (PRWEB) April 19, 2022 The University of Camerino (UniCam) has extended its strategic business partnership with CureLab
CureLab Oncology Launches Veterinary Oncology Subsidiary, CureLab Veterinary
Based on a scientifically solid proof of concept in dogs and cats, an international IP portfolio, and a comprehensive scientific advisory board that includes key opinion leaders and experienced management, CureLab Veterinary intends to raise initial financing through a crowdfunding campaign set to launch within a month, and to become profitable within 36 months of raising funds.
News provided by
Share this article
Share this article
BOSTON, Jan. 21, 2021 /PRNewswire/ CureLab Oncology, a clinical-stage pre-IPO biotech company, has launched CureLab Veterinary, a subsidiary with exclusive worldwide rights to apply CureLab Oncology patents to treat dogs, cats and horses. The first target market for CureLab Veterinary s patented DNA therapeutics will be to treat cancer in dogs and cats.